The 2024 ADA guidelines were released a month or two ago and I wanted to take a little time to digest them before providing my big takeaways. The 2023 guidelines saw a major shift in pharmacotherapy with a strong emphasis on compelling indications and recommended...
When treating hyperglycemia there are two terms that I have seen get confused and often used interchangeably (inappropriately so). Sliding scale and correction factor insulin strategies are NOT the same. These can be tough concepts to differentiate use and know when...
With many insulin formulations on the market, it can be hard to differentiate between similar-acting products and what the best choice may be for our patients. One question raised is what the differences between Novolog versus Fiasp are due to both being insulin...
Diabetic Ketoacidosis (DKA) is traditionally characterized by the triad of hyperglycemia, metabolic acidosis, and ketoacidosis. However, approximately 3% of DKA cases are caused by Euglycemic DKA (EDKA). In the past, this percentage was significantly lower, but the...
The (Board Certified Medication Therapy Management Specialist) BCMTMS exam is a challenging board exam you’ll that thousands of pharmacists have taken or are considering to help demonstrate competency in medication therapy management. Pass rates have ranged down...
